enVVeno Medical Corporation NVNO
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.60% | -11.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.44% | -6.55% | |||
| Operating Income | -19.44% | 6.55% | |||
| Income Before Tax | -21.31% | 6.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -21.31% | 6.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.31% | 6.47% | |||
| EBIT | -19.44% | 6.55% | |||
| EBITDA | -19.97% | 6.60% | |||
| EPS Basic | -17.29% | 8.84% | |||
| Normalized Basic EPS | -15.35% | 8.64% | |||
| EPS Diluted | -17.29% | 8.84% | |||
| Normalized Diluted EPS | -15.35% | 8.64% | |||
| Average Basic Shares Outstanding | 3.43% | 2.60% | |||
| Average Diluted Shares Outstanding | 3.43% | 2.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||